ENTITY
Kintor Pharmaceutical

Kintor Pharmaceutical (9939 HK)

72
Analysis
Health Care • China
Kintor Pharmaceutical is a clinical-stage biotechnology company focused on developing innovative small molecule and biological therapeutics for dermatology and oncology, including treatments for androgenetic alopecia, acne vulgaris, and various cancers. The company also develops high-end cosmetics. Kintor Pharmaceutical was founded in 2009 and is headquartered in Suzhou, People's Republic of China.
more
Exchange Announcement • 29 Sep 2026 19:53

Interim Report 2026

Exchange Announcement • 21 Sep 2026 17:20

Resignation Of Chief Financial Officer, Joint Company Secretary And Process Agent, Appointment Of Chief Financial Officer And Appointment Of Process Agent

Exchange Announcement • 07 Sep 2026 06:07

Voluntary Announcement - Successful Completion Of Long-Term Human Safety Trial Of Kt-939

Exchange Announcement • 19 Aug 2026 22:32

Interim Results Announcement For The Six Months Ended 30 June 2026

Exchange Announcement • 05 Aug 2026 17:10

Date Of Board Meeting

x